(Na/sub x/Ca/sub 1-x/)/sub 3/Co/sub 4/O/sub 9+/spl delta//
In vitro and in vivo targeting imaging of pancreatic cancer using a Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoprobe modified with anti-mesothelin antibody
... The T2 signal values of experimental group xenograft were decreased by 342.533 ± 42.6 after injection of the target probe, and the control group was decreased by − 61.233 ± 33.9 after injection of saline solution, while ...
13
Reactivity of Au/La<sub>1 x</sub>Sr<sub>x</sub>Cr<sub>1 y</sub>Ni<sub>y</sub>O<sub>3 δ</sub> toward Oxidative Coupling of Methane for C<sub>2</sub> and C<sub>3</sub> Hydrocarbons Production
... Fig. 3 show that the average particle size of the perovskite calcined in hydrogen is slightly smaller than the perovskite calcined in the ...0.1 O 3 samples were investigated particle size of gold ...
12
Synthesis of composite magnetic nanoparticles Fe<sub>3</sub>O<sub>4</sub> with alendronate for osteoporosis treatment
... Dex/Fe 3 O 4 using the EDC–NHS crosslinking ...Bis/Dex/Fe 3 O 4 on the bone surface and thermalize by the RF ...Fe 3 O 4 particles. XRD revealed Fe 3 ...
12
Effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> and wogonin on the reversal of multidrug resistance in K562/A02 cell line
... TRIzol. 4 µg of total RNA was added to reverse transcriptase buffer, 25 mmol/L of MgCl 2 , 10 mmol/L deoxyribonucleotide triphosphates, random 9 mers (50 pmol/ µ L), RNase inhibitor (40 U/ µ L), and avian ...
10
Pharmacokinetic parameters and tissue distribution of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles in mice
... ± 9 µ g/g and 211 ± 18 µ g/g, respectively, on day 3 after ...day 3, and thereafter decreased ...Fe 3 O 4 MNPs were higher in the liver and spleen than those in other ...day ...
6
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>@Au composite magnetic nanoparticles in vitro and in vivo
... OH 3 HCl and HAuCl 4 ) were performed during the reaction, and the stirring continued for at least 30 minutes after each ...Fe 3 O 4 @Au composite ...
15
In vitro toxicity of Fe<sub>m</sub>O<sub>n</sub>, Fe<sub>m</sub>O<sub>n</sub>-SiO<sub>2</sub> composite, and SiO<sub>2</sub>-Fe<sub>m</sub>O<sub>n</sub> core-shell magnetic nanoparticles
... NH 4 OH and 1% ammonium acetate was added to FeSO 4 and Fe 2 (SO 4 ) 3 (molar ratio 2:1) in 700 mL of distilled water under intensive stirring at a rate of 4 mL/min until the pH had ...
11
Polyetherimide-grafted Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging
... from healthy Sprague Dawley rats was collected in heparin- coated tubes. The red blood cells (RBCs) were obtained by centrifugation at 1,500 rpm for 5 minutes, and the upper plasma was removed. The RBCs were then washed ...
13
Preparation of Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles coated with gallic acid for drug delivery
... Figure 9, tells us that, after 72 hours of treatment, neither gallic acid nor FCG was toxic to a normal human fibroblast (3T3) cell line tested using various doses ...
12
Carbon dynamics and CO<sub>2</sub> and CH<sub>4</sub> outgassing in the Mekong delta
... in the water column. Our data do not allow us to determine whether these processes mainly occurred in the side chan- nels or in the shrimp farming ponds themselves, although Alongi et al. (1999b) showed a strong ...
23
Synergistic effect of a combination of nanoparticulate Fe<sub>3</sub>O<sub>4</sub> and gambogic acid on phosphatidylinositol 3-kinase/Akt/Bad pathway of LOVO cells
... pro-caspase 9, caspase 9, pro-caspase 3, and caspase ...pro-caspase 9, caspase 9, pro-caspase 3, caspase 3, or β -actin antibody, and then sub- sequently incubated ...
10
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>/DNR magnetic nanoparticles in the treatment of hematologic malignancies
... Fe 3 O 4 ...Fe 3 O 4 -MNPs/DNR groups and negative controls (P ...Fe 3 O 4 -MNPs/DNR was ...Fe 3 O 4 -MNPs/ DNR groups were ...Fe ...
6
Co-encapsulation of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery
... × 4 mm, 60 tumor-bearing mice were randomly assigned to one of the following six treatment groups (n = 10 per group): (1) DOX-MNPs (10 mg/kg, single dose) with an external magnetic field; (2) DOX-MNPs only (10 ...
12
The effects of magnetite (Fe<sub>3</sub>O<sub>4</sub>) nanoparticles on electroporation-induced inward currents in pituitary tumor (GH<sub>3</sub>) cells and in RAW 264.7 macrophages
... Figure 4, when cells were exposed to Fe 3 O 4 NPs (100 µ g/mL), there was a progressive decrease in the activity of MEP-induced channels, which occurred at the level of hyperpolarizing ...
10
Inhibitory effect of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles coloaded with homoharringtonine on human leukemia cells in vivo and in vitro
... As shown in Figure 1A, the polymeric micelles were gener- ated by the hydrophobic interaction of the polyoxyethylene– polyoxypropylene copolymer chain and oleic acid on the surface of iron oxide NPs. The average core ...
10
Preparation and in vitro evaluation of doxorubicin-loaded Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles modified with biocompatible copolymers
... minor modifications. An aqueous solution of doxorubicin 5 mg/5 mL was emulsified in 10 mL dichloromethane, in which 120 mg of the copolymer and 4 mg magnetic nanopar- ticles had been dissolved, using a probe ...
16
Gd<sub>2</sub>O<sub>3</sub> nanoparticles in hematopoietic cells for MRI contrast enhancement
... 2 O 3 ) nanoparticles generate higher relaxivity than currently available Gd chelates: In addition, the Gd 2 O 3 nanoparticles have promising properties for MRI cell ...2 O 3 ...
8
Ultrasmall superparamagnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles: honey-based green and facile synthesis and in vitro viability assay
... The phase structure of the nanoparticles was obtained by X-ray diffraction (Cu K α 1.5406 Å radiation), using a Bruker D8 Advance diffractometer (Bruker AXS, Billerica, MA, USA) at room temperature between 20 ° –25 ° , ...
9
Synergistic effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> with gambogic acid on apoptosis of K562 leukemia cells
... MNPs-Fe 3 O 4 induced apoptosis not only through influencing the regulatory factors in the intrinsic mitochondrial pathway such as bax and bcl-2, but also through regulating the transcription factor ...
9
Fe<sub>3</sub>O<sub>4</sub>/Au magnetic nanoparticle amplification strategies for ultrasensitive electrochemical immunoassay of alfa-fetoprotein
... Fe 3 O 4 /Au strategy as part of a signal amplification procedure and demonstrated its use in the ultrasensitive, selective, and accurate quantification of AFP by electrochemical immunoas- ...Fe ...
11